Form 4: American Healthcare REIT CIO's Stock Transactions

American Healthcare REIT's Chief Investment Officer, Stefan K.L. Oh, reported the vesting and tax-related sale of restricted stock units, alongside the grant of new RSUs.

Summary

• Stefan K.L. Oh, Chief Investment Officer of American Healthcare REIT, Inc. (AHR), reported multiple transactions on March 25, 2026.
• Acquired 9,151 shares of common stock upon the vesting of restricted stock units (RSUs).
• Disposed of 4,657 shares of common stock at $48.25 per share to cover tax obligations related to RSU vesting.
• Acquired an additional 5,086 shares of common stock from RSU vesting.
• Disposed of 2,588 shares of common stock at $48.25 per share for further tax obligations.
• Received a new award of 9,510 time-based RSUs, which will vest ratably on March 10, 2027, 2028, and 2029.
• Following these transactions, Oh beneficially owns 95,430 shares of common stock directly and 19,686 derivative restricted stock units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine but slightly positive event, as the Chief Investment Officer continues to receive new equity awards, aligning his interests with shareholders, despite tax-related sales.

Positives

• The Chief Investment Officer received a new grant of 9,510 restricted stock units, aligning his interests with long-term shareholder value.
• The vesting of RSUs indicates continued retention and incentivization of key management personnel.

Negatives

• A total of 7,245 shares of common stock were disposed of to satisfy tax obligations, reducing direct beneficial ownership.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vestings and subsequent tax-related sales, are common across the REIT sector. The continued grant of equity awards to key executives like the Chief Investment Officer is a standard practice to align management incentives with long-term shareholder interests, reflecting a typical compensation structure in publicly traded real estate investment trusts.

Stakeholder Impact

• Shareholders: The grant of new RSUs to a key executive reinforces alignment between management and shareholder interests, potentially fostering long-term value creation. The tax-related sales are a routine part of executive compensation.

Next Steps

• Future vesting of the 9,510 RSUs awarded on March 25, 2026, on March 10, 2027, 2028, and 2029.
• Future vesting of previously awarded RSUs on March 25, 2027, and March 25, 2028.

Key Dates

Recommendation

This Form 4 details routine insider transactions involving the vesting of restricted stock units, subsequent tax-related sales, and the grant of new equity awards. Such transactions are standard executive compensation events and do not typically signal a significant change in company fundamentals or management's outlook. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment thesis.

Keywords

American Healthcare REIT, AHR, Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Stock Ownership, Chief Investment Officer